Breaking News Bar

Business News and Information

FDA grants two key designations to Passage Bio's experimental Krabbe disease therapy

One of the designations could result in the Philadelphia company receiving a potentially lucrative voucher from the federal agency.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear